688098 申联生物
已收盘 12-20 15:00:01
资讯
新帖
简况
申联生物:12月19日融资净买入648.14万元,连续3日累计净买入2207.48万元
证券之星 · 12-20 10:36
申联生物:12月19日融资净买入648.14万元,连续3日累计净买入2207.48万元
申联生物跌5% 主业不振
智选洞察 · 12-17
申联生物跌5% 主业不振
申联生物12月12日主力资金流入271万元 连续3日加仓
市场透视 · 12-12
申联生物12月12日主力资金流入271万元 连续3日加仓
股票回购增持贷细则已开始执行 已有国有行下发口头通知
21世纪经济报道 · 12-05
股票回购增持贷细则已开始执行 已有国有行下发口头通知
申联生物12月02日主力资金流出19万元 连续3日减仓
市场透视 · 12-02
申联生物12月02日主力资金流出19万元 连续3日减仓
申联生物11月29日遭主力抛售157万元 环比增加528.00%
市场透视 · 11-29
申联生物11月29日遭主力抛售157万元 环比增加528.00%
【读财报】农林牧渔行业信披考评:申联生物、永安林业等8家公司降级
面包财经 · 11-29
【读财报】农林牧渔行业信披考评:申联生物、永安林业等8家公司降级
申联生物:拟回购不低于2000万元且不超过4000万元公司股份
每日经济新闻 · 11-25
申联生物:拟回购不低于2000万元且不超过4000万元公司股份
申联生物(688098.SH)拟斥2000万元至4000万元回购股份
智通财经 · 11-25
申联生物(688098.SH)拟斥2000万元至4000万元回购股份
申联生物:董事长提议2000万元—4000万元回购公司股份
证券 · 11-24
申联生物:董事长提议2000万元—4000万元回购公司股份
申联生物最新公告:拟回购股份金额2000万元至4000万元
证券之星 · 11-24
申联生物最新公告:拟回购股份金额2000万元至4000万元
申联生物:实际控制人之一、董事长提议回购不低于2000万元且不超过4000万元公司股份
每日经济新闻 · 11-24
申联生物:实际控制人之一、董事长提议回购不低于2000万元且不超过4000万元公司股份
申联生物跌5% 主营稳定
智选洞察 · 11-22
申联生物跌5% 主营稳定
申联生物(688098.SH):猪伪狂犬病活疫苗(JS-A1株)获批新兽药
智通财经 · 11-19
申联生物(688098.SH):猪伪狂犬病活疫苗(JS-A1株)获批新兽药
申联生物最新公告:猪伪狂犬病活疫苗(JS-A1株)获批新兽药
证券之星 · 11-19
申联生物最新公告:猪伪狂犬病活疫苗(JS-A1株)获批新兽药
申联生物11月19日获主力加仓201万元 环比增加415.38%
市场透视 · 11-19
申联生物11月19日获主力加仓201万元 环比增加415.38%
申联生物创8个月新高 融资融券实现3连增
智选洞察 · 11-11
申联生物创8个月新高 融资融券实现3连增
申联生物创1个月新高 获主力净流入443万元
智选洞察 · 11-07
申联生物创1个月新高 获主力净流入443万元
申联生物11月06日遭主力抛售593万元 环比增加573.86%
市场透视 · 11-06
申联生物11月06日遭主力抛售593万元 环比增加573.86%
申联生物(688098)9月30日股东户数0.93万户,较上期减少3.75%
证券之星 · 10-31
申联生物(688098)9月30日股东户数0.93万户,较上期减少3.75%
加载更多
公司概况
公司名称:
申联生物医药(上海)股份有限公司
所属行业:
医药制造业
上市日期:
2019-10-28
主营业务:
申联生物医药(上海)股份有限公司是一家专业从事兽用生物制品研发、生产、销售及服务的高新技术企业。公司的主要产品及服务有猪口蹄疫O型合成肽疫苗、猪口蹄疫O型、A型二价合成肽疫苗。公司是高新技术企业,与同行业主要公司相比,公司营业规模相对较小,但猪用生物制品的业务规模位居行业前列。公司产品多次获得殊荣,泰吉联荣获“2022中国猪业赋能荣耀榜之年度匠心疫苗”,“i-DuFil”双膜联用一体纯化技术获第六届中国(上海)国际发明创新展览会金奖,联圆净荣获“年度影响力圆环防控产品”。
发行价格:
8.80
{"stockData":{"symbol":"688098","market":"SH","secType":"STK","nameCN":"申联生物","latestPrice":6,"timestamp":1734678001000,"preClose":5.91,"halted":0,"volume":2478233,"delay":0,"floatShares":411000000,"shares":411000000,"eps":-0.0481,"marketStatus":"已收盘","marketStatusCode":5,"change":0.09,"latestTime":"12-20 15:00:01","open":5.92,"high":6.04,"low":5.87,"amount":14846500,"amplitude":0.0288,"askPrice":6.02,"askSize":48,"bidPrice":6,"bidSize":107,"shortable":0,"etf":0,"ttmEps":-0.0481,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":5.91,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":6.5,"lowLimit":5.32,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":410644000,"pbRate":1.69,"roa":"--","roe":"--","epsLYR":0.08,"committee":-0.205952,"marketValue":2464000000,"floatMarketCap":2464000000,"peRate":-124.740129,"changeRate":0.0152,"turnoverRate":0.006,"status":0,"afterMarket":{"amount":0,"volume":0,"close":6,"buyVolume":0,"sellVolume":0,"time":1734680038975,"indexStatus":"已收盘 12-20 15:30:00","preClose":5.91}},"requestUrl":"/m/hq/s/688098","defaultTab":"news","newsList":[{"id":"2492378494","title":"申联生物:12月19日融资净买入648.14万元,连续3日累计净买入2207.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492378494","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492378494?lang=zh_cn&edition=full","pubTime":"2024-12-20 10:36","pubTimestamp":1734662193,"startTime":"0","endTime":"0","summary":"证券之星消息,12月19日,申联生物(688098)融资买入888.38万元,融资偿还240.25万元,融资净买入648.14万元,融资余额1.47亿元,近3个交易日已连续净买入累计2207.48万元。融券方面,当日无融券交易。融资融券余额1.47亿元,较昨日上涨4.62%。小知识融资融券:目前,个人投资者参与融资融券主要需要具备2个条件:1、从事证券交易至少6个月;2、账户资产满足前20个交易日日均资产50万。融资融券标的:上交所将主板标的股票数量由现有的800只扩大到1000只,深交所将注册制股票以外的标的股票数量由现有的800只扩大到1200只。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220172408ab86945e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220172408ab86945e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688098"],"gpt_icon":0},{"id":"2492377955","title":"申联生物跌5% 主业不振","url":"https://stock-news.laohu8.com/highlight/detail?id=2492377955","media":"智选洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492377955?lang=zh_cn&edition=full","pubTime":"2024-12-17 13:15","pubTimestamp":1734412559,"startTime":"0","endTime":"0","summary":"12月17日,申联生物股价大幅下跌,截至13点15分,申联生物下跌5.11%,报5.94元/股,成交2655万元,换手率1.07%。资金动向截止发稿,申联生物获得主力净流入122万元,其中超大单流入241万元,大单流出119万元。融资融券方面,申联生物12月13日获得融资净买入1085万元,当日该股融资余额为1.25亿元,当较前一日增加9.52%,实现3连增。主营业务及业绩申联生物公司主营业务为兽用生物制品的研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217131603a1f4e35e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217131603a1f4e35e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688098","BK0239"],"gpt_icon":0},{"id":"2491678334","title":"申联生物12月12日主力资金流入271万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491678334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491678334?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:20","pubTimestamp":1733988041,"startTime":"0","endTime":"0","summary":"12月12日, 申联生物股价涨3.45%,报收6.30元,成交金额5341万元,换手率2.12%,振幅5.09%,量比1.97。申联生物今日主力资金净流入271万元,连续3日净流入,上一交易日主力净流入159万元,今日环比增加70.44%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为50.00%,平均涨幅为0.84%。该股近5个交易日上涨11.50%,主力资金累计净流入217万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入153万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212154052a1e870d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212154052a1e870d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688098","BK0239"],"gpt_icon":0},{"id":"2489489861","title":"股票回购增持贷细则已开始执行 已有国有行下发口头通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2489489861","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489489861?lang=zh_cn&edition=full","pubTime":"2024-12-05 15:31","pubTimestamp":1733383860,"startTime":"0","endTime":"0","summary":" 近日,有媒体报道称,对于股票回购增持专项贷款,监管部门在前期执行的基础上,进一步优化了相关细则。 今年10月18日,中国人民银行、金融监管总局、中国证监会发布关于设立股票回购增持再贷款有关事宜的通知。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-12-05/doc-incykxcs9802026.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-05/doc-incykxcs9802026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301070","BK0224","688098","BK0239","001283","BK0259"],"gpt_icon":0},{"id":"2488628249","title":"申联生物12月02日主力资金流出19万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2488628249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488628249?lang=zh_cn&edition=full","pubTime":"2024-12-02 15:21","pubTimestamp":1733124062,"startTime":"0","endTime":"0","summary":"12月02日, 申联生物股价涨3.05%,报收5.75元,成交金额2087万元,换手率0.89%,振幅3.58%,量比1.15。申联生物今日主力资金净流出19万元,连续3日净流出,上一交易日主力净流出157万元,今日环比减少87.90%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为66.67%,平均跌幅为1.46%。该股近5个交易日上涨6.48%,主力资金累计净流出163万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出1022万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202154107abef0c27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202154107abef0c27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688098","BK0239"],"gpt_icon":0},{"id":"2487375584","title":"申联生物11月29日遭主力抛售157万元 环比增加528.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487375584","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487375584?lang=zh_cn&edition=full","pubTime":"2024-11-29 15:20","pubTimestamp":1732864834,"startTime":"0","endTime":"0","summary":"11月29日, 申联生物股价涨2.01%,报收5.58元,成交金额1720万元,换手率0.75%,振幅3.66%,量比0.96。申联生物今日主力资金净流出157万元,上一交易日主力净流出25万元,今日环比增加528.00%。|11月29日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|N联芸|16.64%|#|三丰智能|7.98%|#|省广集团|7.34%|#|兆日科技|6.52%|#|有研新材|6.36%|#|元隆雅图|6.35%|#|威士顿|5.85%|#|巨轮智能|5.67%|#|麦趣尔|5.15%|#|高斯贝尔|5.04%|申联生物所在的动物保健Ⅱ行业,今日主力净流出1472万元,行业排名29/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129153722abe7fc3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129153722abe7fc3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688098","BK0239"],"gpt_icon":0},{"id":"2487222833","title":"【读财报】农林牧渔行业信披考评:申联生物、永安林业等8家公司降级","url":"https://stock-news.laohu8.com/highlight/detail?id=2487222833","media":"面包财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487222833?lang=zh_cn&edition=full","pubTime":"2024-11-29 07:30","pubTimestamp":1732836600,"startTime":"0","endTime":"0","summary":"上交所、深交所每年度组织对上市公司信息披露工作质量进行综合考评并公开发布考评结果。考评结果中,有8家农林牧渔行业公司的信披考评较上一年降级。图1:农林牧渔行业2023-2024信披评级家数从变动情况来看,有82家公司考核评级不变,占79.6%;有8家公司考核评级下降;10家公司评级上升;3家公司首次参与评级。图3:农林牧渔行业2023-2024信披评级升级公司此外,本次考评中有3家农林牧渔行业公司首次被纳入评级,首次评级结果均为B。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129073101abe6f19f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129073101abe6f19f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["000663","688098"],"gpt_icon":0},{"id":"2486085319","title":"申联生物:拟回购不低于2000万元且不超过4000万元公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486085319","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486085319?lang=zh_cn&edition=full","pubTime":"2024-11-25 20:29","pubTimestamp":1732537767,"startTime":"0","endTime":"0","summary":"本次回购的资金总额不低于人民币2000万元(含),不超过人民币4000万元(含)。本次回购股份的价格不超过人民币7.86元/股(含),该价格不高于公司董事会审议通过回购股份方案决议前30个交易日公司股票交易均价的150%。回购期限自董事会审议通过本次回购方案之日起6个月内。2023年1至12月份,申联生物的营业收入构成为:兽用生物制品占比99.55%。截至发稿,申联生物市值为22亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125203005abddbd4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125203005abddbd4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688098","BK0239"],"gpt_icon":0},{"id":"2486308319","title":"申联生物(688098.SH)拟斥2000万元至4000万元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486308319","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486308319?lang=zh_cn&edition=full","pubTime":"2024-11-25 20:20","pubTimestamp":1732537253,"startTime":"0","endTime":"0","summary":"智通财经APP讯,申联生物(688098.SH)披露回购股份方案,公司拟通过集中竞价交易方式回购部分公司已发行的人民币普通股(A股)股票,回购股份金额不低于人民币2000万元(含),不超过人民币4000万元(含),回购股份的价格不超过人民币7.86元/股(含),回购的股份拟用于员工持股计划或者股权激励,或用于转换上市公司发行的可转换为股票的公司债券。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688098","BK0239"],"gpt_icon":0},{"id":"2485697667","title":"申联生物:董事长提议2000万元—4000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2485697667","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485697667?lang=zh_cn&edition=full","pubTime":"2024-11-24 16:11","pubTimestamp":1732435860,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,申联生物(688098)11月24日晚间公告,公司实际控制人之一、董事长聂东升提议2000万元—4000万元回购公司股份,本次回购的股份拟在未来合适时机用于实施员工持股计划或股权激励,或用于转换上市公司发行的可转换为股票的公司债券。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-11-24/doc-incxefeq5810249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688098","BK0239"],"gpt_icon":0},{"id":"2485763044","title":"申联生物最新公告:拟回购股份金额2000万元至4000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485763044","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485763044?lang=zh_cn&edition=full","pubTime":"2024-11-24 15:50","pubTimestamp":1732434635,"startTime":"0","endTime":"0","summary":"申联生物公告,公司实际控制人之一、董事长聂东升基于对公司未来发展的信心和对公司长期价值的认可,提议公司通过集中竞价交易方式回购公司已发行的部分人民币普通股(A股)股票。回购股份拟在未来合适时机用于实施员工持股计划或股权激励,或用于转换上市公司发行的可转换为股票的公司债券。回购价格不高于董事会审议通过回购股份方案决议前30个交易日公司股票交易均价的150%,回购资金总额不低于2000万元(含),不超过4000万元(含),回购期限自董事会审议通过本次回购股份方案之日起6个月内。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112400000974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688098"],"gpt_icon":0},{"id":"2485076370","title":"申联生物:实际控制人之一、董事长提议回购不低于2000万元且不超过4000万元公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2485076370","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485076370?lang=zh_cn&edition=full","pubTime":"2024-11-24 15:49","pubTimestamp":1732434573,"startTime":"0","endTime":"0","summary":"本次回购的资金总额不低于人民币2000万元(含),不超过人民币4000万元(含),具体以董事会审议通过的回购股份方案为准。2023年1至12月份,申联生物的营业收入构成为:兽用生物制品占比99.55%。申联生物的董事长是聂东升,男,64岁,学历背景为本科;总经理是高旭,男,53岁,学历背景为本科。截至发稿,申联生物市值为22亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124155019a25179c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124155019a25179c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688098"],"gpt_icon":0},{"id":"2485663281","title":"申联生物跌5% 主营稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=2485663281","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485663281?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:56","pubTimestamp":1732258609,"startTime":"0","endTime":"0","summary":"11月22日,申联生物股价大幅下跌,截至14点56分,申联生物下跌5.07%,报5.24元/股,成交1726万元,换手率0.78%。资金动向截止发稿,申联生物获得主力净流出63万元。融资融券方面,申联生物11月20日获得融资净买入215万元,当日该股融资余额为1.12亿元,当较前一日增加1.97%,实现3连增。主营业务及业绩申联生物公司主营业务为兽用生物制品的研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122150047abd6a5b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122150047abd6a5b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688098","BK0239"],"gpt_icon":0},{"id":"2484967997","title":"申联生物(688098.SH):猪伪狂犬病活疫苗(JS-A1株)获批新兽药","url":"https://stock-news.laohu8.com/highlight/detail?id=2484967997","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484967997?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:15","pubTimestamp":1732007740,"startTime":"0","endTime":"0","summary":"智通财经APP讯,申联生物(688098.SH)发布公告,根据《兽药管理条例》和《兽药注册办法》规定,经中华人民共和国农业农村部审查,批准公司的猪伪狂犬病活疫苗(JS-A1株)为新兽药。该药品用于预防猪伪狂犬病,免疫后21日产生免疫力,免疫期为6个月。猪伪狂犬病活疫苗(JS-A1株)获批新兽药注册,将进一步丰富公司动物疫苗产品种类,公司非口蹄疫疫苗系列产品也更加丰富,有利于公司为用户尤其是规模化猪场提供一揽子综合疫病防控方案,将进一步提升公司的核心竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688098","BK0239"],"gpt_icon":0},{"id":"2484912992","title":"申联生物最新公告:猪伪狂犬病活疫苗(JS-A1株)获批新兽药","url":"https://stock-news.laohu8.com/highlight/detail?id=2484912992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484912992?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:01","pubTimestamp":1732006879,"startTime":"0","endTime":"0","summary":"申联生物公告,公司猪伪狂犬病活疫苗(JS-A1株)获农业农村部批准为新兽药。该疫苗由申联生物与成都史纪生物制药有限公司、中国农业科学院上海兽医研究所联合研发,用于预防猪伪狂犬病。该产品以猪伪狂犬病毒变异株(JS-2012株)为基础,经体外细胞高温传代致弱的JS-A1株作为生产用毒株,通过微载体悬浮培养生产工艺进行疫苗抗原的制备,结合冻干保护剂制备而成。该疫苗将展现广阔的应用前景,丰富公司动物疫苗产品种类,提升公司核心竞争力。但该产品上市销售前尚需取得产品批准文号批件,公司将积极开展相关工作。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111900027128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688098"],"gpt_icon":0},{"id":"2484499305","title":"申联生物11月19日获主力加仓201万元 环比增加415.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484499305","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484499305?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:20","pubTimestamp":1732000815,"startTime":"0","endTime":"0","summary":"11月19日, 申联生物股价涨1.90%,报收5.35元,成交金额1681万元,换手率0.77%,振幅2.67%,量比0.63。申联生物今日主力资金净流入201万元,上一交易日主力净流入39万元,今日环比增加415.38%。该股近5个交易日下跌5.48%,主力资金累计净流出191万元;近20日主力资金累计净流出522万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119153240abce86f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119153240abce86f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688098","BK0239"],"gpt_icon":0},{"id":"2482221470","title":"申联生物创8个月新高 融资融券实现3连增","url":"https://stock-news.laohu8.com/highlight/detail?id=2482221470","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482221470?lang=zh_cn&edition=full","pubTime":"2024-11-11 14:15","pubTimestamp":1731305736,"startTime":"0","endTime":"0","summary":"11月11日,申联生物股价大幅上涨,截至14点15分,申联生物上涨5.05%,报5.83元/股,创近8个月新高,成交3529万元,换手率1.50%,振幅5.05%。资金动向截止发稿,申联生物获得主力净流出352万元,其中超大单流入54万元,大单流出405万元。融资融券方面,申联生物11月08日获得融资净买入280万元,当日该股融资余额为1.08亿元,当较前一日增加2.67%,实现3连增。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111141548abb4eed7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111141548abb4eed7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688098"],"gpt_icon":0},{"id":"2481916124","title":"申联生物创1个月新高 获主力净流入443万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481916124","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481916124?lang=zh_cn&edition=full","pubTime":"2024-11-07 11:13","pubTimestamp":1730949208,"startTime":"0","endTime":"0","summary":"11月07日,申联生物股价大幅上涨,截至11点13分,申联生物上涨5.17%,报5.49元/股,创近1个月新高,成交2395万元,换手率1.09%,振幅6.13%。资金动向截止发稿,申联生物获得主力净流入443万元,其中超大单流入270万元,大单流入172万元。主营业务及业绩申联生物公司主营业务为兽用生物制品的研发、生产、销售。最新财报显示,今年三季报,申联生物实现营业收入2.48亿元,同比增长3.71%,净利润为-1,412.47万元,同比减少138.05%,基本每股收益为-0.03元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107111334aba84b00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107111334aba84b00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688098"],"gpt_icon":0},{"id":"2481640364","title":"申联生物11月06日遭主力抛售593万元 环比增加573.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481640364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481640364?lang=zh_cn&edition=full","pubTime":"2024-11-06 15:18","pubTimestamp":1730877486,"startTime":"0","endTime":"0","summary":"11月06日, 申联生物股价涨0.38%,报收5.22元,成交金额2614万元,换手率1.22%,振幅2.50%,量比1.30。申联生物今日主力资金净流出593万元,连续3日净流出,上一交易日主力净流出88万元,今日环比增加573.86%。净流出前三个股分别为生物股份、申联生物、金河生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106152750a21ba0d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106152750a21ba0d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688098"],"gpt_icon":0},{"id":"2479774693","title":"申联生物(688098)9月30日股东户数0.93万户,较上期减少3.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479774693","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479774693?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:10","pubTimestamp":1730365846,"startTime":"0","endTime":"0","summary":"证券之星消息,近日申联生物披露,截至2024年9月30日公司股东户数为9288.0户,较6月30日减少362.0户,减幅为3.75%。在动物保健行业个股中,申联生物股东户数低于行业平均水平,截至9月30日,动物保健行业平均股东户数为1.97万户。从股价来看,2024年6月30日至2024年9月30日,申联生物区间涨幅为16.55%,在此期间股东户数减少362.0户,减幅为3.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100033758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688098"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-10-28","address":"上海市闵行区江川东路48号","stockEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0929},{"period":"3month","weight":0.6304},{"period":"6month","weight":0.3575},{"period":"1year","weight":-0.2002},{"period":"ytd","weight":-0.1917}],"companyName":"申联生物医药(上海)股份有限公司","boardCode":"AI0027","perCapita":"44212股","boardName":"医药制造业","registeredCapital":"41064万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":" 申联生物医药(上海)股份有限公司是一家专业从事兽用生物制品研发、生产、销售及服务的高新技术企业。公司的主要产品及服务有猪口蹄疫O型合成肽疫苗、猪口蹄疫O型、A型二价合成肽疫苗。公司是高新技术企业,与同行业主要公司相比,公司营业规模相对较小,但猪用生物制品的业务规模位居行业前列。公司产品多次获得殊荣,泰吉联荣获“2022中国猪业赋能荣耀榜之年度匠心疫苗”,“i-DuFil”双膜联用一体纯化技术获第六届中国(上海)国际发明创新展览会金奖,联圆净荣获“年度影响力圆环防控产品”。","serverTime":1734714120152,"listedPrice":8.8,"stockholders":"9288人(较上一季度减少3.75%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"申联生物(688098)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供申联生物(688098)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"申联生物,688098,申联生物股票,申联生物股票老虎,申联生物股票老虎国际,申联生物行情,申联生物股票行情,申联生物股价,申联生物股市,申联生物股票价格,申联生物股票交易,申联生物股票购买,申联生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"申联生物(688098)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供申联生物(688098)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}